Annihilare Announces a Strategic Partnership in the Healthcare Industry

18 June 2021 | Friday | News

Annihilare Medical Systems Incorporated (AMS) announced today that the company has formed a partnership with DRM MedTec (DRM) in the healthcare space. DRM has exclusive rights to distribute the AMS Healthcare Infection Prevention System (HIPS®).
Image Source : Public Domain

Image Source : Public Domain

The patent pending (US and UK) HIPS® technology is a method using a practical approach, applying both chemistry and technology for complete facility disinfection. Annihilare CEO Marty Paris explains "our system provides unmatched results in disinfection by using the most effective fluids with the most effective cleaning protocol technology. DRM has a wide reach in the healthcare space, and we have a lot of confidence with this partnership."

HIPS® is the most innovative solution on the market today for dealing with Healthcare Associated Infections (HAIs) in all healthcare environments. The system, which produces 500ppm Hypochlorous acid (HOCl) that has an efficacy rate of up to 99.9999% for all current environmental contributing HAIs. HOCl is made from naturally occurring elements, is generated at a pH range of 6.0 to 7.0, and is Green Seal® certified. DRM President, George Morrison, said "HIPS is the most innovative solution that we have found. HIPS is an industry disruptor, and we are very excited about this partnership." 


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in